MYC and cancer: The aberrant activity of SRC in GBM along with the important role of MYC in GBM, led to speculate that the SRC-MYC axis could also have a role in this context and strengthen the hypothesis that targeting SRC could help to defeat cancer-associated adaptation, among which MYC-dependent metabolic reprogramming.